Reports

14158 Results (Page 553 of 567)

All Market Research Reports

Medical Devices

UAE Dental Endodontics Market Analysis

UAE Dental Endodontics Market was valued at $8.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $12.60 Mn by 2030. The key drivers of this industry include growing demand, rising prevalence of dental problems, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Brugada Syndrome Market Analysis

The Egypt Brugada Syndrome Market was valued at $3.4 Mn in 2023 and is predicted to grow at a CAGR of 9.3% from 2023 to 2030, to $6.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the Egypt Brugada Syndrome Market are Raveda Pharma, Eva Pharma, Eipico, Amoun, and Novartis, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

France Blood Disorder Therapeutics Market

France Blood Disorder Therapeutics Market valued at $369 Mn in 2022, projected to reach $610 Mn by 2030 with a 6.5% CAGR. The key drivers of the market include greater disposable income among the French population, leading to an increased ability to afford expensive prescription drugs and specialized treatments for blood problems, and changes in the Western lifestyle causing a higher prevalence of the disease in the country. The France Market encompasses various players across different segments, including Takeda, Roche, Sanofi, Novartis, Novo Nordisk, CSL Ltd, Pfizer, LFB Biomedicaments, Walvax Biotech, Janssen-Cilag etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Clinical Nutrition for Chronic Kidney Diseases Market Analysis

Kenya Clinical Nutrition for Chronic Kidney Diseases Market was valued at $1.10 Mn in 2023 and is predicted to grow at a CAGR of 7.13% from 2023 to 2030, to $1.80 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness and diagnosis, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Brazil Dental Endodontics Market Analysis

Brazil Dental Endodontics Market was valued at $43.80 Mn in 2023 and is predicted to grow at a CAGR of 5.3% from 2023 to 2030, to $62.80 Mn by 2030. The key drivers of this industry include growing demand for cosmetic dentistry, Technological Advancements, rising prevalence of dental problems, and the ageing population. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Brugada Syndrome Market Analysis

The Kenya Brugada Syndrome Market was valued at $0.8 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $1.5 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and increasing healthcare expenditure. The prominent players of the Kenya Brugada Syndrome Market are Siemens Healthcare, Aventis Pasteur, Eli-Lilly, Regal Pharmaceuticals, GSK Nairobi, and Novartis Rhone Poulenic, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Japan Blood Disorder Therapeutics Market

Japan Blood Disorder Therapeutics Market valued at $833 Mn in 2022, projected to reach $1,542 Mn by 2030 with a 8% CAGR. The key drivers of market growth include the higher prevalence of hemophilia A, improved awareness and diagnoses, growing adoption of advanced therapies, and government efforts to support the pharmaceutical industry. The Japan Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, Roche, Bayer, Novartis, KM Pharmaceuticals, Chugai Pharmaceuticals, Eisai, Kyowa Kirin, Daiichi Sankyo, etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Clinical Nutrition for Chronic Kidney Diseases Market Analysis

South Africa Clinical Nutrition for Chronic Kidney Diseases Market was valued at $ 10.20 Mn in 2023 and is predicted to grow at a CAGR of 7.26 % from 2023 to 2030, to $ 16.70 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Brugada Syndrome Market Analysis

The South Africa Brugada Syndrome Market was valued at $7.8 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $14.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the South Africa Brugada Syndrome Market are Sun Pharma, Cipla, Bayer, Sanofi, Aspen Pharmacare, Astellas, and Medtronic, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Blood Disorder Therapeutics Market

Saudi Arabia Blood Disorder Therapeutics Market valued at $228 Mn in 2022, projected to reach $454 Mn by 2030 with a 9% CAGR. Several factors are converging to cause market expansion, such as a young and expanding population, government initiatives supporting improved healthcare accessibility, advocacy groups raising awareness about advanced therapies, and digital healthcare integration. The Saudi Arabia Blood Disorder Therapeutics Market encompasses various players across different segments, including Pfizer, Roche, Takeda Pharmaceuticals, Novartis, Sanofi, Novo Nordisk, Bayer, Jamjoom Pharma, Tabuk Pharma, Tamer Pharma etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

India Clinical Nutrition for Chronic Kidney Diseases Market Analysis

India Clinical Nutrition for Chronic Kidney Diseases Market was valued at $28.60 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $52.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, increased awareness, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

France Dental Endodontics Market Analysis

France Dental Endodontics Market was valued at $48.10 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $60.40 Mn by 2030. The key drivers of this industry include a growing focus on oral health awareness, an aging population, and technological advancement. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

India Brugada Syndrome Market Analysis

The India Brugada Syndrome Market was valued at $21.8 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $44.7 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, advancements in genetic testing, and aging population. The prominent players of the India Brugada Syndrome Market are Intas, Sun Pharmaceuticals, Cipla, Divi's Lab, Dr. Reddy's Laboratories, and Zydus Lifesciences, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Blood Disorder Therapeutics Market

Indonesia Blood Disorder Therapeutics Market valued at $80 Mn in 2022, projected to reach $143 Mn by 2030 with a 7.5% CAGR. The market growth is fuelled due to certain factors such as the increasing incidence of blood disorders in Indonesia, driven by improved diagnostics and accessibility, heightened awareness, identification of genetic and environmental risk factors, and rising investments in healthcare. The Indonesia Blood Disorder Therapeutics Market encompasses various players across different segments, including Roche, Novartis, Pfizer, Bayer, BioMarin Pharmaceutical, Takeda, Kalbe Farma, Dexa Medica, Combiphar, Kimia Farma, etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Medical Devices

Germany Dental Endodontics Market Analysis

Germany Dental Endodontics Market was valued at $64 Mn in 2023 and is predicted to grow at a CAGR of 2.5% from 2023 to 2030, to $76.10 Mn by 2030. The key drivers of this industry include a high focus on oral health, an aging population, and technological advancement. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Canada Breast Pump Market Report

The Canada Breast Pump Market was valued at $235.2 Mn in 2023 and is predicted to grow at a CAGR of 8.6% from 2023 to 2030, to $419 Mn by 2030. The key drivers of the market include the rising female workforce, product innovations, and growing consumer awareness. The prominent players in the Canada Breast Pump Market are Ameda, Avent, Evenflo, Pigeon, Playtex, and Hygeia, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Blood Disorder Therapeutics Market

Kenya Blood Disorder Therapeutics Market valued at $9 Mn in 2022, projected to reach $18 Mn by 2030 with a 8.6% CAGR. The market in Kenya is fuelled due to certain factors such as the increasing prevalence of blood disorders, higher expenditure on healthcare by the government, and the rise in technological innovations leading to safer and personalized medications. The Kenya Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Roche, Novartis, Sun Pharmaceuticals, Regal Pharmaceuticals, Nextgen Pharmaceuticals, Transwide Pharmaceuticals etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Medical Devices

Spain Dental Endodontics Market Analysis

Spain Dental Endodontics Market was valued at $33.80 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $42.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, and growing dental awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

US Breast Pump Market Report

The US Breast Pump Market was valued at $1234.8 Mn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $1931.5 Mn by 2030. The key drivers of the market include the rising female workforce, product innovations, and growing consumer awareness. The prominent players in the US Breast Pump Market are Magento Dr. Brown’s, Freemie, Evenflo, Nuk, Hygeia, Spectra Baby, Willow, Momcozy, and iAPOY, among others.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Blood Disorder Therapeutics Market

Mexico Blood Disorder Therapeutics Market valued at $201 Mn in 2022, projected to reach $365 Mn by 2030 with a 7.75% CAGR. Growth in the market is being driven by Mexico's increasing prevalence of age-related blood diseases, unmet medical needs of the population as well as improvements in treatments like gene and targeted therapy. The Mexico Market encompasses various players across different segments, including Takeda, Sanofi, CSL Ltd, Pfizer, Celgene Corporation, Alexion Pharmaceuticals, Amgen, Laboratorios Grin, PiSA Pharmaceutical Company, Genomma Lab Internacional, etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Clinical Nutrition Market Analysis

The Saudi Arabia Clinical Nutrition Market was valued at $521.4 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $828.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Almarai, Tabuk Pharmaceuticals, Abbott Nutrition, Pfizer Inc, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among other.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

UK Dental Endodontics Market Analysis

UK Dental Endodontics Market was valued at $45.50 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $53.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, technological advancements, and increased awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Saudi Arabia Breast Pump Market Report

The Saudi Arabia Breast Pump Market was valued at $50 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $98 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Saudi Arabia Breast Pump Market are Microlife, Nubeca, Nuby, Bistos, Ameda, Avent, Evenflo, Pigeon, Playtex, and Horigen.

PUBLISHED: Sep, 2024 | FORMAT: PPT | LAST UPDATED: Sep, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Blood Disorder Therapeutics Market

Singapore Blood Disorder Therapeutics Market valued at $16 Mn in 2022, projected to reach $30 Mn by 2030 with a 8.1% CAGR. The market is expanding due to the rising prevalence of blood disorders brought on by aging populations and unhealthy lifestyle choices, therapeutic advancements supported by technology developments, and government programs that fund research and provide affordable therapies. The Singapore Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Pfizer, Bayer, BioLife Sciences, Agenus, Spark Therapeutics, Abeo Therapeutics, etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

Pharmaceuticals

UAE Clinical Nutrition Market Analysis

The UAE Clinical Nutrition Market was valued at $153.3 Mn in 2023 and is projected to grow at a CAGR of 6.34% from 2023 to 2023, to $235.8 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as BASF, B Braun, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc., Otsuka Holdings Co., Ltd among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

subscribe to our newsletter
up